Drug shortages are a complex, global problem.
In most analyses, generic medicines represent the majority of reported shortages, but Innovative Medicines Canada understands the value of public notification of drug shortages and discontinuances. This is why we worked with other stakeholders and Health Canada to develop and launch a website for voluntary industry reporting. Our members have committed to reporting shortages when they know that they will be unable to meet normal, expected patient demand for a drug in Canada. Innovative Medicines Canada members began reporting publicly in October 2011.
Since March 2017, drug shortage reporting became mandatory, and a new website, run on behalf of Health Canada launched – drugshortagescanada.ca